Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Danova

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Haematologica|March 1, 1986
Sequential vincristine, arabinosylcytosine and daunomycin induction therapy in adult acute leukemiaA Riccardi, R Invernizzi, M Girino, et al.
Haematologica|March 1, 1987
In vivo administration of bromodeoxyuridine and flow cytometry for cell kinetic studies in human malignanciesM Danova, G Wilson, A Riccardi, et al.
Anticancer Research|May 1, 1992
Establishment and characterization of two cell lines derived from human glioblastoma multiformeG Bacciocchi, N Gibelli, C Zibera, et al.
British Journal of Cancer|October 1, 1996
Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancerA Ardizzoni, M C Pennucci, M Danova, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2010
Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patientsM Ronzoni, M Manzoni, S Mariucci, et al.
Oncology|March 2, 2011
Immunological effects of bevacizumab-based treatment in metastatic colorectal cancerM Manzoni, B Rovati, M Ronzoni, et al.
Cell Proliferation|September 1, 1991
Expression of cell cycle related proteins--proliferating cell nuclear antigen (PCNA) and statin--during adaptation and de-adaptation of EUE cells to a hypertonic mediumC Pellicciari, M Danova, M Giordano, et al.
Oncology Reports|June 19, 1998
Paclitaxel in anthracycline-treated breast cancer patientsP Pugliese, S Brugnatelli, M Giordano, et al.
British Journal of Cancer|February 1, 1994
Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancerA Ardizzoni, M Venturini, M R Sertoli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancerM Venturini, L Del Mastro, F Testore, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Haematologica|March 1, 1986
Sequential vincristine, arabinosylcytosine and daunomycin induction therapy in adult acute leukemiaA Riccardi, R Invernizzi, M Girino, et al.
Haematologica|March 1, 1987
In vivo administration of bromodeoxyuridine and flow cytometry for cell kinetic studies in human malignanciesM Danova, G Wilson, A Riccardi, et al.
Anticancer Research|May 1, 1992
Establishment and characterization of two cell lines derived from human glioblastoma multiformeG Bacciocchi, N Gibelli, C Zibera, et al.
British Journal of Cancer|October 1, 1996
Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancerA Ardizzoni, M C Pennucci, M Danova, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2010
Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patientsM Ronzoni, M Manzoni, S Mariucci, et al.
Oncology|March 2, 2011
Immunological effects of bevacizumab-based treatment in metastatic colorectal cancerM Manzoni, B Rovati, M Ronzoni, et al.
Cell Proliferation|September 1, 1991
Expression of cell cycle related proteins--proliferating cell nuclear antigen (PCNA) and statin--during adaptation and de-adaptation of EUE cells to a hypertonic mediumC Pellicciari, M Danova, M Giordano, et al.
Oncology Reports|June 19, 1998
Paclitaxel in anthracycline-treated breast cancer patientsP Pugliese, S Brugnatelli, M Giordano, et al.
British Journal of Cancer|February 1, 1994
Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancerA Ardizzoni, M Venturini, M R Sertoli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancerM Venturini, L Del Mastro, F Testore, et al.
Pageof 16